Anti-EphA2 Antibodies with Distinct In Vitro Properties Have Equal In Vivo Efficacy in Pancreatic Cancer

The EphA2 receptor tyrosine kinase is overexpressed in a variety of human epithelial cancers and is a determinant of malignant cellular behavior in pancreatic adenocarcinoma cells. Moreover, it is expressed in tumor endothelium and its activation promotes angiogenesis. To better clarify the therapeu...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Ansuini, Helenia, Meola, Annalisa, Gunes, Zeynep, Paradisi, Valentina, Pezzanera, Monica, Acali, Stefano, Santini, Claudia, Luzzago, Alessandra, Mori, Federica, Lazzaro, Domenico, Ciliberto, Gennaro, Nicosia, Alfredo, La Monica, Nicola, Vitelli, Alessandra
Format: Artigo
Idioma:Inglês
Publicat: Hindawi Publishing Corporation 2009
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2814375/
https://ncbi.nlm.nih.gov/pubmed/20130824
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2009/951917
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars